CD44 is the principal cell surface receptor for HA, and it is widely present in many tumor cells such as pancreatic cancer cells, which suggests that it is promising and significant to use hyaluronan–CD44 interactions as potential targets for early cancer diagnosis [17,18]. The gene discussed is CD44; the disease is cancer.